Letaplimab represents a unique therapeutic strategy for treating complement-mediated diseases. This biologic targets complement component C1q, a critical component of the complement pathway, effectively inhibit its https://oisihdsl668826.blogdigy.com/letaplimab-a-new-therapeutic-approach-65321163